VACCEGEN BIOMEDICALS PRIVATE LIMITED
VACCEGEN BIOMEDICALS PRIVATE LIMITED is a DELHI based PRIVATE LIMITED company, Registered at dated 03-JAN-2012 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of VACCEGEN BIOMEDICALS PRIVATE LIMITED is U24297DL2012PTC229611 and registration number is 229611.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies DELHI India. Authorized share capital of VACCEGEN BIOMEDICALS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 0 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 0.
VACCEGEN BIOMEDICALS PRIVATE LIMITED has 2 directors MAHESH CHAND, LAKHBINDER SINGH,
The registered Email address of VACCEGEN BIOMEDICALS PRIVATE LIMITED is lokhinder10@gmail.com and its registered address is PLOT NO. 85, KHASRA NO: 32/17 HARSH VIHAR, SHAHDARA, DELHI DELHI INDIA 110093 DELHI DELHI india 110093.
The current status of VACCEGEN BIOMEDICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
VACCEGEN BIOMEDICALS PRIVATE LIMITED
DELHI
ACTIVE
METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING
U24297DL2012PTC229611
03 JAN 2012
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
110093
INDIA
PLOT NO. 85, KHASRA NO: 32/17 HARSH VIHAR, SHAHDARA, DELHI DELHI INDIA 110093
lokhinder10@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
05137696 | MAHESH CHAND | Director | 03/01/2012 |
01990863 | LAKHBINDER SINGH | Director | 03/01/2012 |
Details Updated by Companies
Quick Links
- All Registered company of DELHI
- Company Registered in DELHI
- All Registered company of NORTH EAST DELHI in DELHI
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.